B型主动脉壁内血肿与B型主动脉夹层的死亡率和临床结局:系统评价与荟萃分析
该系统评价与荟萃分析比较B型主动脉壁内血肿(IMH)与B型主动脉夹层的死亡率和临床结局。IMH患者总体死亡率与夹层无显著差异(RR 0.74,95%CI 0.37-1.51),但灌注不良发生率显著更低(RR 0.27,95%CI 0.12-0.63)。证据确定性低至极低。
要点
- B型IMH与B型主动脉夹层总体死亡率无显著差异。
- B型IMH患者灌注不良发生率显著低于主动脉夹层。
- IMH患者年龄较夹层患者平均大6.65岁(95%CI 3.87-9.42)。
核心结论
- B型IMH患者灌注不良发生率低于B型主动脉夹层,但两者死亡率和生存结局无显著差异。
- 证据确定性为低至极低,需当代队列和充分随访研究进一步明确预后意义。
研究设计与样本
- 使用ROBINS-I工具评估偏倚风险,GRADE评估证据确定性;采用Cox模型和基于Kaplan-Meier曲线重建数据的限制性平均生存时间进行时间事件分析。
主要发现
- IMH患者年龄大于主动脉夹层患者(平均差+6.65岁,95%CI 3.87-9.42)。
- 总体死亡率在IMH与主动脉夹层间无差异(RR 0.74,95%CI 0.37-1.51;GRADE:极低),合并生存分析(HR 0.98,95%CI 0.54-1.79)和荟萃分析HR(0.87,95%CI 0.32-2.42)结果一致。
- 多个时间 horizons 的限制性平均生存时间分析显示生存无显著差异。
- IMH的灌注不良发生率低于主动脉夹层(RR 0.27,95%CI 0.12-0.63;GRADE:低)。
- 主动脉相关死亡和主动脉破裂无显著差异。
临床怎么用
- 对于B型IMH患者,应关注其较低的灌注不良风险,但死亡率与夹层相当,需同样重视随访和管理。
- 证据确定性低,临床决策应结合个体情况,不能仅凭IMH诊断认为预后更优。
局限性
- 证据确定性低至极低。
- 纳入研究为观察性队列,可能存在偏倚。
- 需要当代队列和充分随访时长的进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare mortality and clinical outcomes between type B intramural haematoma (IMH) and type B aortic dissection, given the absence of synthesised comparative evidence between these two entities. DATA SOURCES: PubMed, Embase, and Cochrane Library. REVIEW METHODS: A systematic search was conducted from inception to October 2025, in accordance with the PRISMA guidelines (PROSPERO; CRD420251158538). Observational cohort studies directly comparing type B IMH with type B aortic dissection were eligible. Risk of bias was assessed using the ROBINS-I tool, and certainty of evidence was evaluated using GRADE. The outcomes included early and overall mortality and malperfusion rates. Time to event analyses were performed using Cox models and restricted mean survival time based on reconstructed data from Kaplan-Meier curves. RESULTS: Nine studies comprising 2 529 patients (2 031 aortic dissection and 498 IMH) were included. Patients with IMH were older than those with aortic dissection (mean difference +6.65 years, 95% confidence interval [CI] 3.87 - 9.42). Overall mortality did not differ between IMH and aortic dissection (risk ratio [RR] 0.74, 95% CI 0.37 - 1.51; GRADE: very low), consistent with pooled survival analysis (hazard ratio [HR] 0.98, 95% CI 0.54 - 1.79) and the meta-analytic HR (0.87, 95% CI 0.32 - 2.42). Similarly, restricted mean survival time analyses across multiple time horizons showed no significant differences in survival. Malperfusion occurred less frequently in IMH than in aortic dissection (RR 0.27, 95% CI 0.12 - 0.63; GRADE: low), whereas no significant differences were observed in aortic related death and aortic rupture. CONCLUSION: Malperfusion occurred less frequently in type B IMH, but no significant difference in mortality or survival outcomes was observed between type B IMH and aortic dissection. The certainty of evidence was low to very low. Further studies involving contemporary cohorts and adequate follow up durations are required to clarify the prognostic implications of these findings.
引用
- Jeon BH, Yoon TH, Cho JW, et al. Mortality and Clinical Outcomes of Type B Aortic Dissection vs. Intramural Haematoma: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 42492762. doi:10.1016/j.ejvs.2026.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。